Taken together, these analyses revealed alterations that would have otherwise been masked in bulk analysis of the OCI-C5x population and indicate that the ERBB2 amplification is present at a low frequency in the original tumor and the OCI-C5x parental line derived from it in vitro. This evidence concerns the gene ERBB2 and neoplasm.